ANDA 211722

TARO PHARMS

FDA Drug Application

Application #211722

Documents

• Letter: 2020-08-26

Application Sponsors

ANDA 211722

TARO PHARMS

Marketing Status

• Prescription: 001

Application Products

001

SPRAY;TOPICAL

EQ 0.05% BASE/SPRAY

0

BETAMETHASONE DIPROPIONATE

BETAMETHASONE DIPROPIONATE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2020-06-17

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001

Prescription

AB

CDER Filings

TARO PHARMS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211722
            [companyName] => TARO PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"BETAMETHASONE DIPROPIONATE","activeIngredients":"BETAMETHASONE DIPROPIONATE","strength":"EQ 0.05% BASE\/SPRAY","dosageForm":"SPRAY;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/17\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-17
        )

)